Lorazepam Injection · #12 of 35 active shortages by FDA posting duration
Brand: LORAZEPAM
FDA lists Lorazepam Injection as Active Shortage (Hospira, Inc., a Pfizer Company).
Availability on file: Limited Availability
Lorazepam Injection: Active Shortage
Limited Availability 11 shortage presentations are tracked for this drug. Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Lorazepam Injection
- Manufacturer
- Hospira, Inc., a Pfizer Company
- Dosage Form
- Injection
- Presentation
- Lorazepam, Injection, 2 mg/1 mL Syringes (NDC 0409-1985-30)
- Package NDC
- 0409-1985-30
Status & Timeline
- Status
- Active Shortage
- Availability
- Limited Availability
- First Reported
- May 3, 2018
- Last Updated
- Mar 13, 2026
- Therapeutic Category
- Neurology
Row fields from the FDA Drug Shortages database via openFDA.
Shortage Reason
Limited Supply Available. Next Delivery: April 2026; Estimated Recovery: June 2026; Shortage per Manufacturer: Manufacturing Delay
Full Drug Profile
lorazepam
Side effects, interactions, warnings & more
Nearby, Other Lorazepam Shortage Records
Lorazepam Injection
Fresenius Kabi USA, LLC
Injection
Lorazepam Injection
Hikma Pharmaceuticals USA, Inc.
Injection
Lorazepam Injection
Hikma Pharmaceuticals USA, Inc.
Injection
Lorazepam Injection
Hikma Pharmaceuticals USA, Inc.
Injection
Lorazepam Injection
Hikma Pharmaceuticals USA, Inc.
Injection
Lorazepam Injection
Hikma Pharmaceuticals USA, Inc.
Injection
FDA reason on file: Limited Supply Available. General shortage guidance lives on the tracker hub.